TCIM
INO icon

TIAA CREF Investment Management’s Inovio Pharmaceuticals INO Stock Holding History

TIAA CREF Investment Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$729K Hold
16,284
– – ﹤0.01% 2453
2018
Q4 		$782K Sell
16,284
-160
-1% -$9.72K ﹤0.01% 2378
2018
Q3 		$1.1M Sell
16,444
-403
-2% -$22.4K ﹤0.01% 2380
2018
Q2 		$792K Buy
16,847
+1,574
+10% +$86.8K ﹤0.01% 2589
2018
Q1 		$863K Sell
15,273
-1,009
-6% -$54.6K ﹤0.01% 2509
2017
Q4 		$807K Sell
16,282
-11,924
-42% -$739K ﹤0.01% 2568
2017
Q3 		$2.15M Buy
28,206
+13,137
+87% +$978K ﹤0.01% 2127
2017
Q2 		$1.42M Sell
15,069
-4,126
-21% -$353K ﹤0.01% 2373
2017
Q1 		$1.52M Sell
19,195
-1,142
-6% -$91K ﹤0.01% 2298
2016
Q4 		$1.69M Sell
20,337
-4,628
-19% -$418K ﹤0.01% 2271
2016
Q3 		$2.79K Sell
24,965
-382
-2% -$42.2K ﹤0.01% 1989
2016
Q2 		$2.81M Buy
25,347
+4,475
+21% +$544K ﹤0.01% 1921
2016
Q1 		$2.18M Hold
20,872
– – ﹤0.01% 2015
2015
Q4 		$1.68M Sell
20,872
-799
-4% -$63.6K ﹤0.01% 2274
2015
Q3 		$1.5M Sell
21,671
-1,859
-8% -$162K ﹤0.01% 2317
2015
Q2 		$2.3M Buy
23,530
+5,385
+30% +$575K ﹤0.01% 2212
2015
Q1 		$1.78M Hold
18,145
– – ﹤0.01% 2292
2014
Q4 		$2M Sell
18,145
-6,857
-27% -$838K ﹤0.01% 2234
2014
Q3 		$2.96M Sell
25,002
-33,468
-57% -$4.17M ﹤0.01% 1969
2014
Q2 		$7.58M Buy
58,470
+851
+1% +$100K 0.01% 1377
2014
Q1 		$9.21M Buy
+57,619
New +$8.27M 0.01% 1186

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TIAA CREF Investment Management's INO Position: Q1 2019 in Review

TIAA CREF Investment Management held its Inovio Pharmaceuticals (INO) position steady in Q1 2019 at 16,284 shares worth $729K. The position accounts for ﹤0.01% of the portfolio, ranked #2453.

TIAA CREF Investment Management first reported a position in INO in Q1 2014 and has held it in 21 quarters since. The position peaked at $9.21M in Q1 2014. 127 funds tracked by Wall St. Rank hold INO as of Q1 2019.

  • TIAA CREF Investment Management held 16,284 shares of Inovio Pharmaceuticals worth $729K as of Q1 2019.
  • TIAA CREF Investment Management left its Inovio Pharmaceuticals share count unchanged in Q1 2019.
  • Inovio Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2453 holding.
  • TIAA CREF Investment Management first reported a position in Inovio Pharmaceuticals in Q1 2014 and has held it in 21 quarters since.
  • TIAA CREF Investment Management's Inovio Pharmaceuticals position peaked at $9.21M in Q1 2014.
  • 127 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.